Zhengyan Zeng

448 total citations
11 papers, 327 citations indexed

About

Zhengyan Zeng is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Zhengyan Zeng has authored 11 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Reproductive Medicine, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in Zhengyan Zeng's work include Thyroid Disorders and Treatments (3 papers), Pregnancy and preeclampsia studies (2 papers) and Reproductive System and Pregnancy (2 papers). Zhengyan Zeng is often cited by papers focused on Thyroid Disorders and Treatments (3 papers), Pregnancy and preeclampsia studies (2 papers) and Reproductive System and Pregnancy (2 papers). Zhengyan Zeng collaborates with scholars based in China. Zhengyan Zeng's co-authors include Meng Rao, Li Tang, Shuhua Zhao, Changhong Zhu, Fang Zhou, Jiang Liu, Ya Wen, Rui Wang, Huawei Wang and Nianyu Li and has published in prestigious journals such as Endocrinology, Journal of Pharmacology and Experimental Therapeutics and Human Reproduction Update.

In The Last Decade

Zhengyan Zeng

10 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengyan Zeng China 8 144 124 108 73 72 11 327
L Ciotta Italy 9 259 1.8× 92 0.7× 209 1.9× 54 0.7× 35 0.5× 22 370
Başak Yıldırım Türkiye 7 211 1.5× 76 0.6× 115 1.1× 28 0.4× 17 0.2× 15 332
J.L. Phy United States 10 340 2.4× 47 0.4× 277 2.6× 42 0.6× 54 0.8× 26 434
Lana Škrgatić Croatia 13 257 1.8× 80 0.6× 160 1.5× 31 0.4× 62 0.9× 23 361
Jolanta Nawrocka-Rutkowska Poland 11 248 1.7× 43 0.3× 125 1.2× 11 0.2× 36 0.5× 31 374
Sylvia Asaka Yamashita Hayashida Brazil 13 321 2.2× 94 0.8× 187 1.7× 21 0.3× 59 0.8× 26 415
C.R. Kennedy United Kingdom 7 247 1.7× 34 0.3× 218 2.0× 72 1.0× 87 1.2× 10 489
Cemil Akgül Türkiye 10 104 0.7× 41 0.3× 104 1.0× 69 0.9× 58 0.8× 18 379

Countries citing papers authored by Zhengyan Zeng

Since Specialization
Citations

This map shows the geographic impact of Zhengyan Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengyan Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengyan Zeng more than expected).

Fields of papers citing papers by Zhengyan Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengyan Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengyan Zeng. The network helps show where Zhengyan Zeng may publish in the future.

Co-authorship network of co-authors of Zhengyan Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengyan Zeng. A scholar is included among the top collaborators of Zhengyan Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengyan Zeng. Zhengyan Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Zeng, Zhengyan, Shuhua Zhao, Li Tang, et al.. (2021). Humanin Alleviates Insulin Resistance in Polycystic Ovary Syndrome: A Human and Rat Model–Based Study. Endocrinology. 162(8). 18 indexed citations
3.
Li, Nianyu, Zhengyan Zeng, Li Tang, et al.. (2020). Humanin regulates oxidative stress in the ovaries of polycystic ovary syndrome patients via the Keap1/Nrf2 pathway. Molecular Human Reproduction. 27(2). 57 indexed citations
5.
Rao, Meng, Zhengyan Zeng, Fang Zhou, et al.. (2019). Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis. Human Reproduction Update. 25(3). 344–361. 93 indexed citations
6.
Rao, Meng, Fang Zhou, Li Tang, et al.. (2018). Follicular fluid humanin concentration is related to ovarian reserve markers and clinical pregnancy after IVF–ICSI: a pilot study. Reproductive BioMedicine Online. 38(1). 108–117. 25 indexed citations
8.
Rao, Meng, Zhengyan Zeng, & Li Tang. (2018). Maternal physical activity before IVF/ICSI cycles improves clinical pregnancy rate and live birth rate: a systematic review and meta-analysis. Reproductive Biology and Endocrinology. 16(1). 11–11. 48 indexed citations
9.
Rao, Meng, et al.. (2017). Next-generation sequencing-based microRNA profiling of mice testis subjected to transient heat stress. Oncotarget. 8(67). 111672–111682. 22 indexed citations
10.
Rao, Meng, Zhengyan Zeng, Yi Zheng, et al.. (2017). Prevalence and risk factors of lower urinary tract symptoms in Chinese adult men: a multicentre cross-sectional study. Oncotarget. 8(68). 113225–113238.
11.
Zeng, Zhengyan, et al.. (2015). Variation of reproductive hormone profile in male patients with obstructive sleep apnea: a meta-analysis. Sleep and Biological Rhythms. 14(2). 125–133. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026